androstanes - CISMeF

Preferred Label : androstanes;

MeSH definition : The family of steroids from which the androgens are derived.;

MeSH annotation : do not confuse with ANDROSTENES;

Is substance : O;

Détails

Origin ID

D000731;

UMLS CUI

C0002854;

ATC code(s)
- androstan derivatives [ATC Code]
Allowable qualifiers
- administration and dosage [MeSH Qualifier]
- adverse effects [MeSH Qualifier]
- agonists [MeSH Qualifier]
- analysis [MeSH Qualifier]
- antagonists and inhibitors [MeSH Qualifier]
- blood [MeSH Qualifier]
- cerebrospinal fluid [MeSH Qualifier]
- chemical synthesis [MeSH Qualifier]
- chemistry [MeSH Qualifier]
- classification [MeSH Qualifier]
- contraindications [MeSH Qualifier]
- economics [MeSH Qualifier]
- history [MeSH Qualifier]
- immunology [MeSH Qualifier]
- isolation and purification [MeSH Qualifier]
- metabolism [MeSH Qualifier]
- pharmacokinetics [MeSH Qualifier]
- pharmacology [MeSH Qualifier]
- poisoning [MeSH Qualifier]
- radiation effects [MeSH Qualifier]
- standards [MeSH Qualifier]
- supply and distribution [MeSH Qualifier]
- therapeutic use [MeSH Qualifier]
- toxicity [MeSH Qualifier]
- urine [MeSH Qualifier]
Ne pas confondre avec
- androstenes [MeSH Descriptor]
Record concept(s)
- androstanes [MeSH concept]
Related MeSH Supplementary Concept(s)
- 1-(3-hydroxy-17-acetyloxy)-2-(1.4-dioxa-8-azaspiro-(4,5)-dec-8-yl)-(5alpha-androstane-16-yl)-1-(2-propenyl) pyrrolidine [MeSH Supplementary Concept]
- 15,16-epoxyandrostan-17-one [MeSH Supplementary Concept]
- 17-acetamidoandrostane [MeSH Supplementary Concept]
- 17-acetoxyandrostan-3-one [MeSH Supplementary Concept]
- 17-amino-4-azaandrostane [MeSH Supplementary Concept]
- 17-benzyl-5-androstane-3,17-diol [MeSH Supplementary Concept]
- 17-isopentyloxy-4-azaandrostane [MeSH Supplementary Concept]
- 1alpha-triazolyl-5alpha-androstane [MeSH Supplementary Concept]
- 2-(4'-methyl-1'-piperazinyl)-3-hydroxyl-5-androstane-17-one [MeSH Supplementary Concept]
- 3 beta-hydroxy-13 alpha-amino-13,17-seco-5 alpha-androstan-17-oic-13,17-lactam [MeSH Supplementary Concept]
- 3,11,17-trioxoandrostane-5-carbonitrile [MeSH Supplementary Concept]
- 3,3-difluoro-5alpha-androstan-17-one [MeSH Supplementary Concept]
- 3,4-epoxy-5alpha-androstan-17-one [MeSH Supplementary Concept]
- 3-(3alpha-hydroxy-3beta-methyl-5alpha-androstan-17beta-yl)-5-(hydroxymethyl)isoxazole [MeSH Supplementary Concept]
- 3-(N-heptanoyl-phenylalanine-leucine-aminomethyl)-3-hydroxy-5-androstan-17-one [MeSH Supplementary Concept]
- 3-acetoxy-17-prolylaminoandrostane [MeSH Supplementary Concept]
- 3-hydroxy-17-aza-D-homoandrostan-4-N,N-bis(2-chloroethyl)aminophenylacetate [MeSH Supplementary Concept]
- 3-hydroxy-N-methyl-17-aza-D-homoandrostan-17-one-4-N,N-bis(2-chloroethyl)aminophenylacetate [MeSH Supplementary Concept]
- 3-keto-5,10-epoxy-19-normethylandrostan-17-one [MeSH Supplementary Concept]
- 3-oxo-androstan-17-yl-(2'',2'',6'',6''-tetramethyl-N-oxyl)piperidyl butan-1',4'-dioate [MeSH Supplementary Concept]
- 4,5-epoxyandrostan-3-one [MeSH Supplementary Concept]
- 5,6-epoxyandrosta-4,7,17,19-tetraone [MeSH Supplementary Concept]
- 5,6-epoxyandrosta-4,7,17-trione [MeSH Supplementary Concept]
- 5,6-epoxyandrosta-7,17,19-trione [MeSH Supplementary Concept]
- 6-oxonimonol [MeSH Supplementary Concept]
- ANQ 9040 [MeSH Supplementary Concept]
- HS 342 [MeSH Supplementary Concept]
- KAN 610857 [MeSH Supplementary Concept]
- KSR592 [MeSH Supplementary Concept]
- L 636028 [MeSH Supplementary Concept]
- LNF 209 [MeSH Supplementary Concept]
- N-4(benzylbenzoyl)-3-oxo-4-aza-4-methyl-5-androstane-17-carboxamide [MeSH Supplementary Concept]
- RM-532-105 [MeSH Supplementary Concept]
- RU 5135 [MeSH Supplementary Concept]
- SKF 105111 [MeSH Supplementary Concept]
- WIN 51708 [MeSH Supplementary Concept]
- androst-17beta-amide [MeSH Supplementary Concept]
- androstan-17-one [MeSH Supplementary Concept]
- androstane [MeSH Supplementary Concept]
- ascandroside [MeSH Supplementary Concept]
- clionastatin A [MeSH Supplementary Concept]
- clionastatin B [MeSH Supplementary Concept]
- dihydrochandonium [MeSH Supplementary Concept]
- etianic acid [MeSH Supplementary Concept]
- furazadrol [MeSH Supplementary Concept]
- nimonol [MeSH Supplementary Concept]
- samandarone [MeSH Supplementary Concept]
- spiro(3'-(3'-N-morpholino-2'-(3'''-cyclopentylpropionyloxy)propyl)-2'-oxooxazolidin-5'-yl)androstan-17-one [MeSH Supplementary Concept]
- spiro(androstan-3,2'-oxiran)-17-one [MeSH Supplementary Concept]
Semantic type(s)
- Biologically Active Substance [UMLS semantic type]
- Organic Chemical [UMLS semantic type]
UMLS correspondences (same concept)
- Androstane (substance) [SNOMED CT concept]
- Product containing androstane (product) [SNOMED CT concept]
Validated automatic mappings to BTNT
- Androstane (substance) [SNOMED CT concept]

Position du mot-clé dans l'(les) arborescence(s) :

Vous pouvez consulter :

recommendations
documents concerning education
documents for patients